[Tissue reactions of human breast in leukemias].

G. Seifert

DOI: https://doi.org/10.1007/BF00963744

1952-10-09

Virchows Archiv für Pathologische Anatomie und Physiologie und für Klinische Medizin

Abstract:

What problem does this paper attempt to address?

[Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].

G. di Martino,F. Iannucci,A. Bizzarro,G. Iacono

Abstract:The Authors have tested serum levels of CEA, ferritin, Alpha-1-antitrypsin, parathyroid hormone (PTH) and calcitonin (CT) in 286 patients affected by lung, gastrointestinal, breast and other kinds of cancer and by non neoplastic diseases. 50 healthy subjects were tested as matched controls too. None of the tested patients was subjected to blood transfusion, therapy with iron, radio- or chemotherapy before the blood drawing. Cea, ferritin, PTH and CT were tested by radioimmunoassay; AAT by laser nephelometry. All the healthy subjects showed serum levels of the markers in the normal ranges. Also the percent of cases with contemporaneous pathological markers was examined. The obtained data have been statistically controlled with "chi square" test. The results show that CEA, ferritin, AAT and CT are higher in the tumor groups than in the others. On the contrary PTH seems to be not useful as tumor marker. The Authors conclude affirming that it is not possible to use any of the tested substances as a specific tumor marker but it is useful to test at the same time these markers in the patients suspected to be affected by cancer for an early diagnosis and therapy, as there are few false positive and false negative cases.
High-power chargers for electric vehicles: are they safe for patients with pacemakers and defibrillators?

Carsten Lennerz,Claudia Schaarschmidt,Patrick Blažek,Katharina Knoll,Marc Kottmaier,Tilko Reents,Felix Bourier,Sarah Lengauer,Miruna Popa,Katharina Wimbauer,Fabian Bahlke,Hannah Krafft,Florian Englert,Lena Friedrich,Heribert Schunkert,Gabriele Hessling,Isabel Deisenhofer,Christof Kolb,Matthew O'Connor

DOI: https://doi.org/10.1093/europace/euad042

2023-04-17

EP Europace

Abstract:Abstract Aims Battery electric vehicle (BEV) sales and use are rapidly expanding. Battery electric vehicles, along with their charging stations, are a potential source of electromagnetic interference (EMI) for patients with cardiac implantable electronic devices (CIEDs). The new ‘high-power’ charging stations have the potential to create strong electromagnetic fields and induce EMI in CIEDs, and their safety has not been evaluated. Methods and results A total of 130 CIED patients performed 561 charges of four BEVs and a test vehicle (350 kW charge capacity) using high-power charging stations under continuous 6-lead electrocardiogram monitoring. The charging cable was placed directly over the CIED, and devices were programmed to maximize the chance of EMI detection. Cardiac implantable electronic devices were re-interrogated after patients charged all BEVs and the test vehicle for evidence of EMI. There were no incidences of EMI, specifically no over-sensing, pacing inhibition, inappropriate tachycardia detection, mode switching, or spontaneous reprogramming. The risk of EMI on a patient-based analysis is 0/130 [95% confidence interval (CI) 0%–2%], and the risk of EMI on a charge-based analysis is 0/561 (95% CI 0%–0.6%). The effective magnetic field along the charging cable was 38.65 μT and at the charging station was 77.9 μT. Conclusions The use of electric cars with high-power chargers by patients with cardiac devices appears to be safe with no evidence of clinically relevant EMI. Reasonable caution, by minimizing the time spent in close proximity with the charging cables, is still advised as the occurrence of very rare events cannot be excluded from our results.

cardiac & cardiovascular systems
Electromagnetic simulation and electromagnetic safety characteristics analysis of implantable medical devices in wireless charging processes

Kai Che,Peng Yang,Peng Luo,Jinxing Yu,Haiping Hou,Xiangnan Niu,Yunqian Gong,Chongming Chen

DOI: https://doi.org/10.3233/jcm-247457

2024-08-18

Journal of Computational Methods in Sciences and Engineering

Abstract:In recent years, wireless charging technology for electric vehicles has received increasing attention. Existing research has been limited to the safety of specific body parts in the electromagnetic environment of wireless charging for electric vehicles, with insufficient consideration for the overall human body and the electromagnetic safety of implanted medical devices. In order to assess its safety in the electromagnetic environment more comprehensively, a three-dimensional electromagnetic simulation software based on the finite element method is used to construct models of the human body and implanted medical devices in the electromagnetic environment of wireless charging for electric vehicles. The study aims to investigate the impact of this electromagnetic environment on the human body and implanted medical devices. The results indicate that, except for the maximum magnetic induction of 0.47 μT at the ankle, which exceeds the limit, the magnetic induction intensity and electric field strength in important tissue areas, especially the upper trunk of the human body, are both below the safety limits specified by the International Commission on Non-Ionizing Radiation Protection (ICNIRP) guidelines. For implanted cardiac pacemakers, the effective and peak magnetic field strengths are 13.7 A/m and 19.4 A/m, respectively, when the coil input power is 22 kW, meeting the relevant magnetic field strength requirements. The maximum temperature rise of the pacemaker is 3.2 × 10-3∘C, and there are no significant changes in the temperature of the major organs in the human body after the implantation of the pacemaker. The thermal effects of electromagnetic waves on the temperature rise caused by implanted cardiac pacemakers have minimal impact on the human body.
Safety Evaluation of Medical Implants in the Human Body for a Wireless Power Transfer System in an Electric Vehicle

Izaz Ali Shah,Youngdae Cho,Hyoungsuk Yoo

DOI: https://doi.org/10.1109/temc.2020.3023734

IF: 2.036

2021-06-01

IEEE Transactions on Electromagnetic Compatibility

Abstract:One of the important safety aspects regarding electromagnetic fields is their coupling with medical implants in the human body. In this article, an adult model (Ella), with different medical implants, was exposed to a leaked magnetic field from a wireless power transfer (WPT) system in an electric vehicle, operating at a frequency of 85 kHz, with transferred powers of 3.7, 7.7, 11, and 22 kW. The induced electric field (E-field) in the human model, standing close to the vehicle and sitting inside the vehicle, was evaluated with a prosthetic hip implant, an interlocking nail implant, an InterStim neurostimulator implant, a traditional pacemaker implant, and a leadless pacemaker implant. The results indicated that medical implants influenced the maximum magnitude of the induced E-field and its distribution inside the body. A notable enhancement in the E-field was observed around the implants. In worst-case scenarios, the effects of implant shape and size were investigated. The highest induced E-field (12.68 V/m) was observed with the interlocking nail of length 340 mm for standing posture, which exceeded the prescribed limit of 11.5 V/m in the International Commission on Non-Ionizing Radiation Protection guidelines. The presence of a medical implant in the body likely limits the transferred power of the WPT system, depending on the implant type, size, location, and the body posture.

telecommunications,engineering, electrical & electronic
Active implantable medical device EMI assessment for wireless power transfer operating in LF and HF bands

Takashi Hikage,Toshio Nojima,Hiroshi Fujimoto

DOI: https://doi.org/10.1088/0031-9155/61/12/4522

IF: 3.5

2016-05-25

Physics in Medicine and Biology

Abstract:The electromagnetic interference (EMI) imposed on active implantable medical devices by wireless power transfer systems (WPTSs) is discussed based upon results of in vitro experiments. The purpose of this study is to present comprehensive EMI test results gathered from implantable-cardiac pacemakers and implantable cardioverter defibrillators exposed to the electromagnetic field generated by several WPTSs operating in low-frequency (70 kHz-460 kHz) and high-frequency (6.78 MHz) bands. The constructed in vitro experimental test system based upon an Irnich's flat torso phantom was applied. EMI test experiments are conducted on 14 types of WPTSs including Qi-compliant system and EV-charging WPT system mounted on current production EVs. In addition, a numerical simulation model for active implantable medical device (AIMD) EMI estimation based on the experimental test system is newly proposed. The experimental results demonstrate the risk of WPTSs emitting intermittent signal to affect the correct behavior of AIMDs when operating at very short distances. The proposed numerical simulation model is applicable to obtain basically the EMI characteristics of various types of WPTSs.

engineering, biomedical,radiology, nuclear medicine & medical imaging
Electromagnetic interference in pacemaker patients

Jan Steffel

DOI: https://doi.org/10.1093/med/9780198784906.003.0466

2018-07-01

Abstract:In spite of the development of specific shielding of electronic devices as well as the current-day preference for bipolar sensing, electromagnetic interference (EMI) may still occur with certain pacemakers in certain settings, which in turn may lead to false inhibition of ventricular stimulation with potentially fatal consequences. The most important sources of clinically relevant EMI include medical diagnostics and therapy (e.g. magnetic resonance imaging, radiofrequency ablation, cardioversion/defibrillation, and electrocautery), the working environment (including high-power lines, combustion/degaussing/welding equipment, and others), as well as sources from daily life (such as wireless mobile phones, metal detectors, household appliances such as induction furnaces, electronic article surveillance devices, and others). To what extent, and whether or not at all, any given source of interference leads to EMI depends on several factors including the duration of interference, the field strength, and the frequency spectrum of the source. In addition, lead properties and device programming are important determinants. Awareness, recognition, and avoidance of EMI sources is of paramount importance, particularly in high-risk pacemaker-dependent individuals. The importance of proper education of patients as well as healthcare providers cannot be overemphasized.
Infant mortality in Bekaa-Lebanon, 1979.

I. Shibaru,I. Tabbarah,H. Zurayk,M. Muhana,E. Gangarosa

Lebanese Medical Journal

Abstract: The study purpose was to determine the magnitude of infant mortality in the Bekka Mohafazat of Lebanon, to define its major causes, to try to correlate it with other possible influencing factors, and to determine whether the implementation of a new program for the treatment of diarrhea and prevention of its complications (sponsored by UN Agencies) should be a priority for Lebanon. The previously estimated birthrate for rural areas in Lebanon was 40/1000 and the estimated infant mortality rate was 60/1000. For this study to include around 60 cases of infant death, a sample of at least 25,000 was necessary. All newborns in the August 1976 to August 1979 period were studied; this meant 16 villages in 4 Qada's of Bekaa. A standard questionnaire was designed so that data could be obtained to record birthrate, infant mortality, causes of infant deaths and some other parameters. Parents were asked whether infants who died experienced diarrhea, respiratory symptoms, rash, or other major signs prior to death. The total sample size was 10,923. There were 997 newborns in the study period; 53 of these infants died within the 1st year of life. Data obtained for the whole Bekaa Mohafazat revealed a birthrate of 30.4/1000 and an infant mortality rate of 53.1/1000. Qada Baalbeck showed the highest birthrate (36.4/1000) as well as infant mortality rate (66.2/1000). The lowest infant mortality rate was found in Qada's Zahle (39.1/1000), and the lowest birthrate was noted in Qada's Hermel (18.9/1000). Of the total infant deaths, 47.1% had diarrhea prior to death and 43.4% had undefined conditions which reflects the parents' inability to assess objectively and to remember correctly the conditions of their infants before deaths. The remaining 9.5% cases had cough or rash prior to death. The study was conducted during July and August when diarrheal diseases are generaely more common, and this might have led to an overreporting of diarrhea as a condition prior to death. Prior to death, 50.8% of total deaths were treated in a hospital; 69.8% were treated by a physician at different levels of health care. No correlation was found between infant mortality and feeding habits of the newborns. No correlation was found between infant mortality and the mother's age and education, birth order, sex and age at death of the newborn.
Deep brain stimulation and electromagnetic interference

Shervin Rahimpour,Musa Kiyani,Sarah E Hodges,Dennis A Turner

DOI: https://doi.org/10.1016/j.clineuro.2021.106577

Abstract:Deep brain stimulation (DBS) has evolved into an approved and efficacious treatment for movement, obsessive-compulsive, and epilepsy disorders that are refractory to medical therapy, with current investigation into other disease conditions. However, there are unintentional and intentional sources of external electromagnetic interference (EMI) that can lead to either malfunctioning or damaged DBS devices, as well as injury to human tissue. Comprehensive studies and guidelines on such topics in the medical literature are scarce. Herein, we review the principles behind EMI, as well as the various potential sources of interference, both unintentional (e.g. stray EMI fields) and intentional (e.g. MRI scans, "brainjacking"). Additionally, we employ the Manufacturer and User Device Facility Experience (MAUDE) database to assess real-world instances of EMI (e.g., airport body scanners, magnetic resonance imaging (MRI), and electrosurgery) affecting DBS devices commonly implanted in the United States (US).
Complex Electromagnetic Issues Associated with the Use of Electric Vehicles in Urban Transportation

Krzysztof Gryz,Jolanta Karpowicz,Patryk Zradziński

DOI: https://doi.org/10.3390/s22051719

IF: 3.9

2022-02-22

Sensors

Abstract:The electromagnetic field (EMF) in electric vehicles (EVs) affects not only drivers, but also passengers (using EVs daily) and electronic devices inside. This article summarizes the measurement methods applicable in studies of complex EMF in EVs focused on the evaluation of characteristics of such exposure to EVs users and drivers, together with the results of investigations into the static magnetic field (SMF), the extremely low-frequency magnetic field (ELF) and radiofrequency (RF) EMF related to the use of the EVs in urban transportation. The investigated EMF components comply separately with limits provided by international labor law and guidelines regarding the evaluation of human short-term exposure; however other issues need attention—electromagnetic immunity of electronic devices and long-term human exposure. The strongest EMF was found in the vicinity of direct current (DC) charging installations—SMF up to 0.2 mT and ELF magnetic field up to 100 μT—and inside the EVs—up to 30 μT close to its internal electrical equipment. Exposure to RF EMF inside the EVs (up to a few V/m) was found and recognized to be emitted from outdoor radiocommunications systems, together with emissions from sources used inside vehicles, such as passenger mobile communication handsets and antennas of Wi-Fi routers.

engineering, electrical & electronic,chemistry, analytical,instruments & instrumentation
Human Exposure Influence Analysis for Wireless Electric Vehicle Battery Charging

Adel El-Shahat,Joshua Danjuma,Almoataz Y. Abdelaziz,Shady H. E. Abdel Aleem

DOI: https://doi.org/10.3390/cleantechnol4030048

2022-08-15

Clean Technologies

Abstract:Wireless charging schemes aim to counter some drawbacks of electric vehicles’ wired charging, such as the fact that it does not encourage mobility, leads to safety issues regarding high voltage cables, power adapters high cost, and has more battery waste by companies. In this paper, a comparative study of wireless power transfer multiple coil geometries is performed to analyze the efficiency, coupling coefficient, mutual inductance, and magnetic flux density production for each geometry. Results show that coil geometry, current excitation, and shielding techniques within the Wireless Electric Vehicle Charging (WEVC) system substantially influence magnetic flux leakage. In addition, the paper proposes an analytical framework for a WEVC scheme via electromagnetic resonance coupling. Safety considerations of the WEVC system, including the effects on humans, are investigated in several scenarios based on the relative location of the human while EV charging is conducted as the leading paper’s goal. The exposure measurements are performed across various radial distances from the coils using 3-D FEA ANSYS Maxwell Software (American technology company, Pennsylvania, United States). The analysis shows that WEVC systems can achieve high power transfer, resulting in increased magnetic flux leakage around the coils. The safe distance for humans and animals during the charging sequence is attained from research results. For instance, in the 120 mm spiral coil, 120 mm square coil, and 600 mm spiral coil operating at 1 A, excitation, the SAR levels are under the threshold of 700 mm away from the coils. For the 600 mm spiral coil excited at 8 A, the SAR levels fall under the threshold at 900 mm away from the coils. When shielding is utilized, the safe distance is improved by up to 350 mm. Considering the regulations of the Non-Ionizing Radiation Protection (ICNIRP) standards, 600 mm is a safe distance away from the coils, and, vertically, anywhere past 300 mm is safe for humans.
Extravascular Implantable Cardioverter-Defibrillator Sensing and Detection in a Large Global Population

Charles Swerdlow,Jeff Gillberg,Lucas V.A. Boersma,Jaimie Manlucu,Xusheng Zhang,Yan Zhang,Alfonso Aranda Hernandez,Varun Bhatia,Francis Murgatroyd

DOI: https://doi.org/10.1016/j.jacep.2024.02.033

IF: 6.124

2024-05-17

JACC Clinical Electrophysiology

Abstract:Background The extravascular (EV) implantable cardioverter-defibrillator (ICD) includes features to address sensing and arrhythmia detection challenges presented by its substernal lead location. Objectives In this study, the authors sought to evaluate sensing and detection performance in 299 patients discharged with an EV-ICD in the global pivotal study. Methods We reviewed and adjudicated all induced ventricular fibrillation (VF) episodes and spontaneous device-stored episodes that satisfied rate and duration criteria in a programmed ventricular tachycardia (VT)/VF therapy zone. Results At implantation, all EV-ICDs detected induced VF at the programmed sensitivity; 95.9% detected VF with a 3× safety margin. In follow-up, EV-ICDs detected all 59 VT/VF episodes that sustained until therapy. Of 1,034 non-VT/VF episodes, oversensing caused 87.9% and supraventricular tachycardia caused 12.1%. Therapy was withheld in 80.9%, aborted in 10.6%, and delivered in 8.5%. The most common causes of oversensing were myopotentials (61.2%) and P-wave oversensing (PWOS) (19.9%). Inappropriate shocks occurred in only 3.2% of myopotential episodes, but in 21.8% of PWOS episodes. Myopotential oversensing was more common with Ring-Can sensing ( P < 0.0001) and correlated with low R-wave amplitude ( P < 0.0001). PWOS occurred almost exclusively with Ring1-Ring2 sensing ( P = 0.0001) and began with transient decrease in R-wave or increase in P-wave amplitude ( P < 0.0001). In software emulation, a new PWOS discriminator significantly reduced total inappropriate detections. Conclusions In a global population, EV-ICD detected induced and spontaneous VT/VF accurately. Although discriminators withheld detection from most non-VT/VF episodes, inappropriate shocks were common. The most common cause was PWOS, which may be reduced by optimizing sensing at implantation and incorporation of the PWOS discriminator, which is now in the current device. (Extravascular ICD Pivotal Study [EV ICD]; NCT04060680 )

cardiac & cardiovascular systems
Left Ventricular Assist Device Implantation Outcomes In Patients With Subcutaneous Implantable Cardioverter-defibrillators: A Case Series

Stephen Allan Petty,Steven J. Ross,William M. Miles,Eric Jeng,Mohammad Al-Ani,Alex Parker,Juan Vilaro,Juan Aranda,Mustafa M. Ahmed

DOI: https://doi.org/10.1016/j.cardfail.2023.10.254

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:Introduction Patients undergoing left ventricular assist device (LVAD) implantation for advanced heart failure may have a previously implanted implantable cardioverter-defibrillator (ICD) for primary or secondary prevention of sudden cardiac death. Electromagnetic interference (EMI) has been reported following LVAD implantation in patients with traditional transvenous ICDs, leading to inappropriate device shocks. Recently, subcutaneous ICDs (SICDs) have gained popularity due to their lower risk of infectious-related complications and preservation of vascular access. Little is known about the impacts of LVAD implantation on patients with SICDs, and particularly about the effects of LVAD-related EMI with these devices. Hypothesis Like traditional ICD systems, SICDs may be prone to EMI following LVAD implantation. As such, patients with preexisting SICDs may be at risk for inappropriate device shocks after LVAD placement. Methods We retrospectively reviewed the outcomes in 6 patients at a single center with nonischemic cardiomyopathy and subcutaneous ICDs who underwent HeartMate 3 LVAD implantation between August 2022 and January 2023. Data including incidence of VT/VF, device interrogations, appropriate and inappropriate device therapies were collected. Results The mean age was 46 years old, and 2 patients (33%) were female. Additionally, 2 patients (33%) had experienced VT/VF prior to ICD implantation. The mean time between SICD implantation and LVAD implantation was 70 months. Inappropriate shocks due to LVAD-related EMI were experienced by 3 patients (50%). Device therapies were disabled after inappropriate shock in these patients and additionally disabled in 2 other patients (for a total of 5/6 patients). Therapies remained activated without EMI or inappropriate shock in 1 patient. Extraction of the SICD was performed for 1 of the patients who experienced EMI-related shock and 1 patient's SICD lead was intentionally transected during LVAD implantation. Of the patients who experienced EMI-related shocks, 2 occurred within 24 hours of LVAD implantation and 1 occurred 33 days following LVAD implantation. Pre- and post-implant SICD EGMs demonstrated a loss of signal fidelity and EMI after LVAD implantation in these patients [Figure 1]. Conclusions Among patients with SICDs undergoing LVAD implantation, there was a very high incidence of EMI leading to inappropriate device therapies. We suggest deactivation prior to LVAD implantation. Caution should be taken prior to reactivation of therapies to verify the absence of EMI. Permanent deactivation and/or device removal following LVAD implantation can also be considered.

cardiac & cardiovascular systems
Bench study of the accuracy of a commercial AED arrhythmia analysis algorithm in the presence of electromagnetic interferences

Irena Jekova,Vessela Krasteva,Sarah Ménétré,Todor Stoyanov,Ivaylo Christov,Roman Fleischhackl,Johann-Jakob Schmid,Jean-Philippe Didon

DOI: https://doi.org/10.1088/0967-3334/30/7/012

2009-06-12

Physiological Measurement

Abstract:This paper presents a bench study on a commercial automated external defibrillator (AED). The objective was to evaluate the performance of the defibrillation advisory system and its robustness against electromagnetic interferences (EMI) with central frequencies of 16.7, 50 and 60 Hz. The shock advisory system uses two 50 and 60 Hz band-pass filters, an adaptive filter to identify and suppress 16.7 Hz interference, and a software technique for arrhythmia analysis based on morphology and frequency ECG parameters. The testing process includes noise-free ECG strips from the internationally recognized MIT-VFDB ECG database that were superimposed with simulated EMI artifacts and supplied to the shock advisory system embedded in a real AED. Measurements under special consideration of the allowed variation of EMI frequency (15.7-17.4, 47-52, 58-62 Hz) and amplitude (1 and 8 mV) were performed to optimize external validity. The accuracy was reported using the American Heart Association (AHA) recommendations for arrhythmia analysis performance. In the case of artifact-free signals, the AHA performance goals were exceeded for both sensitivity and specificity: 99% for ventricular fibrillation (VF), 98% for rapid ventricular tachycardia (VT), 90% for slow VT, 100% for normal sinus rhythm, 100% for asystole and 99% for other non-shockable rhythms. In the presence of EMI, the specificity for some non-shockable rhythms (NSR, N) may be affected in some specific cases of a low signal-to-noise ratio and extreme frequencies, leading to a drop in the specificity with no more than 7% point. The specificity for asystole and the sensitivity for VF and rapid VT in the presence of any kind of 16.7, 50 or 60 Hz EMI simulated artifact were shown to reach the equivalence of sensitivity required for non-noisy signals. In conclusion, we proved that the shock advisory system working in a real AED operates accurately according to the AHA recommendations without artifacts and in the presence of EMI. The results may be affected for specificity in the case of a low signal-to-noise ratio or in some extreme frequency setting.

engineering, biomedical,biophysics,physiology
The development of the extravascular defibrillator with substernal lead placement: A new Frontier for device-based treatment of sudden cardiac arrest

Amy E Thompson,Brett Atwater,Lucas Boersma,Ian Crozier,Gregory Engel,Paul Friedman,J Rod Gimbel,Bradley P Knight,Jaimie Manlucu,Francis Murgatroyd,David O'Donnell,Juergen Kuschyk,Paul DeGroot

DOI: https://doi.org/10.1111/jce.15511

Abstract:Introduction: The extravascular implantable cardioverter-defibrillato (EV ICD) system with substernal lead placement is a novel nontransvenous alternative to current commercially available ICD systems. The EV ICD provides defibrillation and pacing therapies without the potential long-term complications of endovascular lead placement but requires a new procedure for implantation with a safety profile under evaluation. Methods: This paper summarizes the development of the EV ICD, including the preclinical and clinical evaluations that have contributed to the system and procedural refinements to date. Results: Extensive preclinical research evaluations and four human clinical studies with >140 combined acute and chronic implants have enabled the development and refinement of the EV ICD system, currently in worldwide pivotal study. Conclusion: The EV ICD may represent a clinically valuable solution in protecting patients from sudden cardiac death while avoiding the long-term consequences of transvenous hardware. The EV ICD offers advantages over transvenous and subcutaneous systems by avoiding placement in the heart and vasculature; relative to subcutaneous systems, EV ICD requires less energy for defibrillation, enabling a smaller device, and provides pacing features such as antitachycardia and asystole pacing in a single system.
General Voltage Injection Device for Immunity Test of Active Implantable Neurostimulators to Electromagnetic Fields over the Frequency Range 16.6hz to 80Mhz

Bing Li,Weiming Wang,Feng Wu,Chunhua Hu,Fangjun Liu,Luming Li

DOI: https://doi.org/10.1109/embc.2019.8856466

2019-01-01

Abstract:A general voltage injection testing device is presented to test the immunity of active implantable neurostimulator (INS) to electromagnetic fields over the frequency range 16.6Hz to 80MHz. The proposed device consists of test circuit and transfer tooling, which is designed to conduct Electromagnetic Compatibility (EMC) test of INS with output-only functionality. In the test circuit, a tissue-electrode interface model and its board layout are provided to satisfy impedance continuity and test channel consistency. In order to adapt to different types of stimulators and electrode specifications, transfer circuits and several kinds of transfer tooling are created. In accordance with ISO14708-3, Voltage injection tests have been carried out with the device and an INS with 16 electrodes. The results show that the device can meet test requirements and is useful for EMC test. Besides, the device can provide references for other manufacturers and organizations to accomplish voltage injection test.
Hybrid Cathode Lithium Battery Discharge Simulation for Implantable Cardioverter Defibrillators Using a Coupled Electro-Thermal Dynamic Model

Mahsa Doosthosseini,Hamed Ghods,Mahdi Khajeh Talkhoncheh,Jeffrey L. Silberberg,Sandy Weininger

DOI: https://doi.org/10.1007/s13239-023-00676-0

2023-08-12

Cardiovascular Engineering and Technology

Abstract:This paper explores the effect of the load imposed by implantable cardioverter defibrillators (ICDs) on their lithium battery power sources longevity using a simulation approach that incorporates a coupled electro-thermal dynamic model. ICDs are one of the effective treatments available to significantly improve survival of patients with fatal arrhythmia (abnormal heart rhythm) disorders. Using a lithium battery power source, this life-saving device sends electrical shocks or pulses to regulate the heartbeat. The service life and reliability of an ICD is primarily expressed by its battery's lifespan and performance. In this paper we investigate the terminal voltage, depth of discharge and temperature dynamics of the implantable lithium battery with a combined cathode material, namely silver vanadium oxide and carbon-monofluoride (Li/SVO-CF x ). Modeling the implantable batteries characteristics is a well-established topic in literature; however, to the best of the author's knowledge, the impact of the high-energy shocks (defibrillation) and low-energy device power supply (housekeeping) on the ICD's battery operation is relatively less-explored. Our analysis reveals that the battery terminal voltage is primarily influenced by the continuous low-level housekeeping discharge current within the range of micro amps, rather than the intermittent high-level demand of defibrillation current within the range of several amperes. A Monte Carlo simulation and model prediction comparison with real-time experimental data from literature were used to assess the accuracy and applicability of the model. The results can be used to improve the device battery design, control and operation, thus extending the service life in patients and reducing the need for invasive replacement surgery.

engineering, biomedical,cardiac & cardiovascular systems
Primary Experimental Study on Safety of Deep Brain Stimulation in Rf Electromagnetic Field

Xu Jun,Li Luming,Hao Hongwei

DOI: https://doi.org/10.1109/iembs.2009.5332538

2009-01-01

Abstract:With the rapid growth of clinical application of Deep Brain Stimulation, its safety and functional concern in the electromagnetic field, another pollution becoming much more serious, has become more and more significant. Meanwhile, the measuring standards on Electromagnetic Compatibility (EMC) for DBS are still incomplete. Particularly, the knowledge of the electromagnetic field induced signals on the implanted lead is ignorant while some informal reports some side effects. This paper briefly surmised the status of EMC standards on implantable medical devices. Based on the EMC experiments of DBS device we developed, two experiments for measuring the induced voltage of the deep brain stimulator in RF electromagnetic field were reported. The measured data showed that the induced voltage in some frequency was prominent, for example over 2V. As a primary research, we think these results would be significant to cause researcher to pay more attention to the EMC safety problem and biological effects of the induced voltage in deep brain stimulation and other implantable devices.
New-generation electronic appliances and cardiac implantable electronic devices: a systematic literature review of mechanisms and in vivo studies

Jakrin Kewcharoen,Kuldeep Shah,Rahul Bhardwaj,Tahmeed Contractor,Mohit K. Turagam,Ravi Mandapati,Dhanunjaya Lakkireddy,Jalaj Garg

DOI: https://doi.org/10.1007/s10840-024-01777-z

2024-03-06

Journal of Interventional Cardiac Electrophysiology

Abstract:Cardiac implantable electronic device (CIED) functions are susceptible to electromagnetic interference (EMI) from electromagnetic fields (EMF). Data on EMI risks from new-generation electronic appliances (EA) are limited.

cardiac & cardiovascular systems
Safety of non-invasive brain stimulation in patients with implants: a computational risk assessment

Fariba Karimi,Antonino M Cassarà,Myles Capstick,Niels Kuster,Esra Neufeld

DOI: https://doi.org/10.1088/1741-2552/ad8efa

IF: 5.043

2024-11-07

Journal of Neural Engineering

Abstract:Objective: Non-invasive brain stimulation (NIBS) methodologies, such as transcranial electric (tES) are increasingly employed for therapeutic, diagnostic, or research purposes. The concurrent presence of active/passive implants can pose safety risks, affect the NIBS delivery, or generate confounding signals. A systematic investigation is required to understand the interaction mechanisms, quantify exposure, assess risks, and establish guidance for NIBS applications. Approach: We used measurements, simplified generic, and detailed anatomical modeling to: (i) systematically analyze exposure conditions with passive and active implants, considering local field enhancement, exposure dosimetry, tissue heating and neuromodulation, capacitive lead current injection, low-impedance pathways between electrode contacts, and insulation damage; (ii) identify risk metrics and efficient prediction strategies; (iii) quantify these metrics in relevant exposure cases and (iv) identify worst case conditions. Various aspects including implant design, positioning, scar tissue formation, anisotropy, and frequency were investigated. Results: At typical tES frequencies, local enhancement of dosimetric exposure quantities can reach up to one order of magnitude for deep brain stimulation (DBS) and stereoelectroencephalography implants (more for elongated passive implants), potentially resulting in unwanted neuromodulation that can confound results but is still 2-3 orders of magnitude lower than active DBS. Under worst-case conditions, capacitive current injection in the active implants' lead can produce local exposures of similar magnitude as the passive field enhancement, while capacitive pathways between contacts are negligible. Above 10 kHz, applied current magnitudes increase, necessitating consideration of tissue heating. Furthermore, capacitive effects become more prominent, leading to current injection that can reach DBS-like levels. Adverse effects from abandoned/damaged leads in direct electrode vicinity cannot be excluded. Significance: Safety related concerns of tES application in the presence of implants are systematically identified and explored, resulting in specific and quantitative guidance and establishing basis for safety standards. Furthermore,several methods for reducing risks are suggested while acknowledging the limitations(see Sec. 4.5).

engineering, biomedical,neurosciences
Investigation of Electromagnetic Exposure of WPT Coil to Human Body Based on Biological Electromagnetic Safety Assessment

Hongyan Sun,Shiliang Hou,Yang Zhao,Wei Yan,Yongji Wu

DOI: https://doi.org/10.13052/2021.aces.j.361012

2021-11-21

The Applied Computational Electromagnetics Society Journal (ACES)

Abstract:When the wireless power transmission (WPT) system of electric vehicle(EV) is working, the leakage of high frequency electromagnetic field (EMF) to the non-working area will be threaten to human safety. According to SAE J2954 standard, the coupling coils modeling of WPT and car shell modeling are established. WPT's bit-directional guidance technology and deviation correction control strategy are given. According to the harm degree of SAR, power density P, current density J and magnetic induction intensity B to human body when the human model is in different positions of standing, lying and sitting, the comprehensive harm index of electromagnetic radiation Σhurt is creatively proposed to assess the electromagnetic radiation hazard of EV. Field circuit co-simulation helps us to study the bio-electromagnetic safety of WPT in vehicle environment. A human exposure EMF joint test system is designed and made to measure vehicle’s surrounding EMF. Through simulation and experimental verification, WPT coil’s electromagnetic exposure level to the human body inside the EV meets the requirements of ICNIRP, the EMF at the ankle outside the EV exceeds the standard and needs to be protected.

[Tissue reactions of human breast in leukemias].

[Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].

High-power chargers for electric vehicles: are they safe for patients with pacemakers and defibrillators?

Electromagnetic simulation and electromagnetic safety characteristics analysis of implantable medical devices in wireless charging processes

Safety Evaluation of Medical Implants in the Human Body for a Wireless Power Transfer System in an Electric Vehicle

Active implantable medical device EMI assessment for wireless power transfer operating in LF and HF bands

Electromagnetic interference in pacemaker patients

Infant mortality in Bekaa-Lebanon, 1979.

Deep brain stimulation and electromagnetic interference

Complex Electromagnetic Issues Associated with the Use of Electric Vehicles in Urban Transportation

Human Exposure Influence Analysis for Wireless Electric Vehicle Battery Charging

Extravascular Implantable Cardioverter-Defibrillator Sensing and Detection in a Large Global Population

Left Ventricular Assist Device Implantation Outcomes In Patients With Subcutaneous Implantable Cardioverter-defibrillators: A Case Series

Bench study of the accuracy of a commercial AED arrhythmia analysis algorithm in the presence of electromagnetic interferences

The development of the extravascular defibrillator with substernal lead placement: A new Frontier for device-based treatment of sudden cardiac arrest

General Voltage Injection Device for Immunity Test of Active Implantable Neurostimulators to Electromagnetic Fields over the Frequency Range 16.6hz to 80Mhz

Hybrid Cathode Lithium Battery Discharge Simulation for Implantable Cardioverter Defibrillators Using a Coupled Electro-Thermal Dynamic Model

Primary Experimental Study on Safety of Deep Brain Stimulation in Rf Electromagnetic Field

New-generation electronic appliances and cardiac implantable electronic devices: a systematic literature review of mechanisms and in vivo studies

Safety of non-invasive brain stimulation in patients with implants: a computational risk assessment

Investigation of Electromagnetic Exposure of WPT Coil to Human Body Based on Biological Electromagnetic Safety Assessment